Contract Manufacturing (Co-Man) M&A Trends
Contract manufacturing companies, co-manufacturers and co-packers producing food and beverage products on behalf of brand owners, are valued in the lower middle market primarily on capacity utilization, a metric consistently overlooked by founders but weighted heavily by buyers. Auctus Capital Partners advises co-man founders through sell-side transactions where quantifying capacity utilization explicitly, alongside managing customer concentration constructively, are the two clearest paths to a strong outcome.
Key Takeaways
01
PE-driven consolidation in contract manufacturing is creating platform acquisition demand for co-man facilities with proven, diversified operations, a favorable dynamic for founders whose businesses fit the specific operational profile these buyers seek.
02
Contract manufacturing companies trade at 4x to 7x EBITDA, with capacity utilization above 75% and a diversified customer base of five or more meaningful accounts positioning a company toward the top of that range.
03
Capacity utilization, explicitly quantified by facility and shift, is the most influential and most commonly under-communicated value driver in co-man M&A, and founders should present this metric directly rather than leaving buyers to estimate it independently.
04
Contract manufacturing companies that quantify capacity utilization explicitly, maintain quality certifications, and structure customer relationships with meaningful contractual protections consistently achieve the upper end of the co-man EBITDA multiple range.
Why Are Co-Manufacturing Companies Attractive M&A Targets?
Private equity firms have become increasingly active acquirers of contract manufacturing companies, building multi-facility platforms designed to serve large CPG brands that increasingly prefer working with scaled, geographically diversified co-manufacturing partners rather than fragmented single-facility operators. This consolidation thesis mirrors the roll-up economics seen in other fragmented service sectors, acquiring individual co-man facilities and integrating them into a platform that can offer brand clients multi-region production capacity, redundancy, and standardized quality systems.
For co-man founders, this creates a genuinely favorable environment, but one that rewards a specific operational profile. Buyers are not simply acquiring production capacity; they are acquiring proven capacity utilization, diversified customer relationships, and quality certifications that reduce the integration risk of folding a facility into a larger platform.
How Are Contract Food Manufacturers Valued?
Co-manufacturing companies typically trade at EBITDA multiples of 4x to 7x in the lower middle market, a narrower and generally lower range than branded CPG companies, reflecting the fundamentally different value proposition. Co-man valuations are driven by capacity utilization, customer diversification, and margin structure rather than brand equity, since co-manufacturers by definition do not own the consumer-facing brand relationship.
Premium multiples within this range are reserved for companies operating at 75% or higher capacity utilization with a diversified customer base, typically five or more meaningful client relationships, rather than dependence on one or two anchor accounts. Companies operating below 60% capacity utilization, even if profitable, signal underutilized fixed assets that a buyer will need to address post-acquisition, which introduces execution risk that gets priced into a lower multiple.
What Operational Metrics Drive Co-Man Valuations?
Capacity utilization is the single most influential, and most commonly under-communicated, value driver in co-man M&A. Founders frequently present financial performance without explicitly quantifying utilization rates, leaving buyers to estimate this critical metric independently, often conservatively. Auctus Capital Partners ensures every co-man CIM presents capacity utilization explicitly, by facility and by shift, because this single data point often shifts a buyer’s entire framing of the acquisition opportunity.
Quality certifications, including SQF (Safe Quality Food) certification and FDA registration status, function as a baseline credibility signal rather than a differentiator, but their absence is disqualifying for buyers serving brand clients with strict supplier qualification requirements. Beyond baseline compliance, buyers evaluate specialized capabilities (allergen-free production lines, organic certification, specific packaging formats) that expand the addressable client base and reduce switching costs for existing customers.
Capacity Utilization and Valuation
4x-7x EBITDA
Contract manufacturing companies trade in a defined multiple range, with premium outcomes reserved for companies that demonstrate high utilization, diversified customer relationships, and strong operational controls.
Below 60%
Companies operating below 60% utilization signal underutilized fixed assets that a buyer will need to address post-acquisition, introducing execution risk that gets priced into a lower multiple.
75%+ Premium Threshold
Companies operating above 75% utilization with a diversified customer base are positioned toward the top of the 4x-7x range, reflecting stronger execution, lower integration risk, and more durable margin structure.
5 Meaningful Accounts
A diversified customer base with five or more meaningful relationships reduces concentration risk and supports a stronger valuation outcome, especially when those relationships are supported by multi-year contracts and volume commitments.
Operational Metrics That Drive Valuation
1
Capacity Utilization
Explicitly quantified by facility and shift, this metric is the most influential value driver in co-man M&A and should be presented directly rather than left for buyers to estimate.
2
Customer Diversification
Five or more meaningful accounts reduce concentration risk and support a stronger valuation outcome, especially when those relationships are supported by multi-year contracts and volume commitments.
3
Quality Certifications
SQF certification and FDA registration status are baseline requirements for buyers serving brand clients with strict supplier qualification standards, and their absence is disqualifying.
4
Specialized Capabilities
Allergen-free lines, organic certification, and specific packaging formats expand the addressable client base and reduce switching costs for existing customers, making the business more attractive to platform buyers.
Frequently Asked Questions About Contract Manufacturing M&A
1
What EBITDA multiples do co-manufacturing companies typically achieve?
Contract manufacturing companies typically achieve EBITDA multiples of 4x to 7x in the lower middle market. Companies operating at 75% or higher capacity utilization with a diversified customer base of five or more meaningful accounts trade toward the top of this range, while companies with lower utilization or significant customer concentration trade toward the bottom.
2
How does customer concentration risk affect a co-man's sale?
Customer concentration is a genuine risk factor in co-man M&A, but it is manageable rather than disqualifying when contract terms include meaningful protections. A co-manufacturer with one or two anchor clients representing the majority of revenue can still achieve a strong outcome if those relationships are governed by multi-year contracts with minimum volume commitments and reasonable termination notice periods. Buyers evaluate the contractual protection around concentrated relationships as much as the concentration percentage itself; a well-protected concentrated relationship is viewed more favorably than a loosely structured diversified customer base with no volume commitments at all.
Value Your Contract Manufacturing Business
Begin with a confidential valuation of your contract manufacturing business.